about
Inhibrx Inc is a clinical-stage biotechnology company focused on developing a pipeline of novel biologic therapeutic candidates. It combines an understanding of target biology with protein engineering, proprietary discovery technologies, and an integ...
Read More
74.66
-4.83
(-6.08%)
122.1K
XNAS Volume
XNAS 23 Jan, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Inhibrx Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..